Abstract
Mass spectrometry has already become an indispensable tool in the analytical armamentarium of the biopharmaceutical industry, although its current uses are limited to characterization of covalent structure of recombinant protein drugs. However, the scope of applications of mass spectrometry-based methods is beginning to expand to include characterization of the higher order structure and dynamics of biopharmaceutical products, a development which is catalyzed by the recent progress in mass spectrometry-based methods to study higher order protein structure. The two particularly promising methods that are likely to have the most significant and lasting impact in many areas of biopharmaceutical analysis, direct ESI MS and hydrogen/deuterium exchange, are focus of this article.
Keywords: Analytical characterization, biopharmaceuticals, charge state distribution, electrospray ionization, ion fragmentation, hydrogen/deuterium exchange, higher order structure protein, therapeutics, mass spectrometry, protein conformation, protein interaction, higher order protein structure, biopharmaceutical analysis, direct ESI MS, Analysis of Conformational Integrity of Biopharmaceutical Products
Current Pharmaceutical Biotechnology
Title: Advanced Mass Spectrometry-Based Methods for the Analysis of Conformational Integrity of Biopharmaceutical Products
Volume: 12 Issue: 10
Author(s): Cedric E. Bobst and Igor A. Kaltashov
Affiliation:
Keywords: Analytical characterization, biopharmaceuticals, charge state distribution, electrospray ionization, ion fragmentation, hydrogen/deuterium exchange, higher order structure protein, therapeutics, mass spectrometry, protein conformation, protein interaction, higher order protein structure, biopharmaceutical analysis, direct ESI MS, Analysis of Conformational Integrity of Biopharmaceutical Products
Abstract: Mass spectrometry has already become an indispensable tool in the analytical armamentarium of the biopharmaceutical industry, although its current uses are limited to characterization of covalent structure of recombinant protein drugs. However, the scope of applications of mass spectrometry-based methods is beginning to expand to include characterization of the higher order structure and dynamics of biopharmaceutical products, a development which is catalyzed by the recent progress in mass spectrometry-based methods to study higher order protein structure. The two particularly promising methods that are likely to have the most significant and lasting impact in many areas of biopharmaceutical analysis, direct ESI MS and hydrogen/deuterium exchange, are focus of this article.
Export Options
About this article
Cite this article as:
E. Bobst Cedric and A. Kaltashov Igor, Advanced Mass Spectrometry-Based Methods for the Analysis of Conformational Integrity of Biopharmaceutical Products, Current Pharmaceutical Biotechnology 2011; 12 (10) . https://dx.doi.org/10.2174/138920111798357311
DOI https://dx.doi.org/10.2174/138920111798357311 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug release from ordered mesoporous silicas
Current Pharmaceutical Design A Piece of the ROCK: A Critical Role for Rho Kinases in the Nervous System
Current Neurovascular Research miRNAs in Alzheimer Disease – A Therapeutic Perspective
Current Alzheimer Research The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
Current Neuropharmacology How Does Indoleamine 2,3-Dioxygenase Contribute to HIV-Mediated Immune Dysregulation
Current Drug Metabolism Successive Stability Indicating Spectrophotometric Technique for Simultaneous Determination of Quetiapine Fumarate and its Three Major Related Compounds
Current Analytical Chemistry Motor and Anxiety Effects of PNU-282987, An Alpha7 Nicotinic Receptor Agonist, and Stress in an Animal Model of Alzheimer’s Disease
Current Alzheimer Research Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD)
Current Respiratory Medicine Reviews <i>In-silico</i> Prediction of the Beta-carboline Alkaloids Harmine and Harmaline as Potent Drug Candidates for the Treatment of Parkinson’s disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets Knowing When to Trust Your Gut: The Intimate Relationship Between Neurodegenerative Diseases and the Brain-Gut Axis
Current Neurovascular Research Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Current Neuropharmacology Antiepileptic Drug Monotherapy: The Initial Approach in Epilepsy Management
Current Neuropharmacology Controlled Parenteral Formulations: An Efficacious and Favourable Way to Deliver the Anti-psychotic Drugs
Current Psychiatry Research and Reviews Stem Cell Research and Therapy for Liver Disease
Current Stem Cell Research & Therapy The Roles of the Unique Prolyl Isomerase Pin1 in Cancer-Related Viral and Bacterial Infections
Current Molecular Medicine Beta-Amyloid, Oxidative Stress and Down Syndrome
Current Alzheimer Research Neurotoxins: Free Radical Mechanisms and Melatonin Protection
Current Neuropharmacology Clinical Determinants of Cognition Levels in French Cocaine Addicted Patients
Current Pharmaceutical Design Oxidative Stress and Neurodegenerative Diseases: Looking for a Therapeutic Solution Inspired on Benzopyran Chemistry
Current Topics in Medicinal Chemistry